ELIZABETH MILLER: Open Payments
NPI 1346795309 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,216 · 2025 $591
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $310 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| ABBVIE INC. | 2 | $57 |
| Janssen Biotech, Inc. | 1 | $37 |
| AERIN MEDICAL INC. | 1 | $23 |
| GENZYME CORPORATION | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Organon LLC | 1 | $21 |
| UCB, Inc. | 1 | $19 |
Products named: TAVNEOS, KRYSTEXXA, COSENTYX, TREMFYA, SKYRIZI, VIVAER STYLUS, KEVZARA, RINVOQ.
Industry payments across MD — which companies pay providers there.
